Following SARS-CoV-2 infection, women more likely to develop long COVID-19 syndrome than men
WEDNESDAY, June 22, 2022 (HealthDay News) — There are sex-related differences in COVID-19 sequelae and long COVID-19 syndrome, according to a review published online June 20 in Current Medical Research and Opinion.
Shirley V. Sylvester, M.D., M.P.H., from Johnson & Johnson in New Brunswick, New Jersey, and colleagues conducted a literature review to understand sex differences in sequelae from COVID-19 as well as long COVID-19 syndrome.
The researchers identified 23 eligible studies evaluating COVID-19 sequelae and 12 for long COVID-19 syndrome (more than 1.3 million patients). Among women (versus men), COVID-19 sequelae in the categories of psychiatric/mood; ear, nose, or throat (ENT); musculoskeletal; and respiratory disorders were significantly more likely, while renal sequelae were more likely among men than women. Women had a greater likelihood of having long COVID-19 syndrome, including for ENT, gastrointestinal, psychiatric/mood, neurological, dermatological, and other disorders. Odds of endocrine and renal disorders were significantly higher among men.
“Few COVID-19 studies report sex-disaggregated data, underscoring the need for further sex-based research/reporting of COVID-19 disease,” the authors write.
Several authors disclosed financial ties to Johnson & Johnson, which funded the study.
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Parts of the World Seeing New COVID-19 Variant 
HHS, NIH Unveil Vaccine Initiative to Protect Against Future Pandemics 
Hospital-Onset SARS-CoV-2 Infection During Omicron Linked to Morbidity 
Staffing, Scheduling, and Wage Changes Could Reattract Nurses Back to Hospitals 
Skilled Nursing Facility Capacity Declined Between 2019 and 2024 
Physical Design of Critical Care Units Influences Nursing Culture 
Low Capability Pediatric Hospitals More Than Doubled From 2003 to 2022 
